Vertebral Osteomyelitis
8
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Evaluation of the Evolution of Patient Care Within the Spinal Pathology Department
INfectious DIsease REgistry BIObank
Spine Registry University Hospital of Cologne- Department of Orthopedics
Immobilization and Neurological Complications in Patients With Vertebral Osteomyelitis.
Conservative Versus Surgical Treatment of Native Vertebral Osteomyelitis
Ceftriaxone as Home IV for Staph Infections
Characterization and Differential Diagnosis of Vertebral Osteomyelitis
Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis